Stock Price Quote

INDRAPRASTHA MEDICAL CORPORATION LTD.

NSE : INDRAMEDCOBSE : 532150ISIN CODE : INE681B01017Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE188.05-3.35 (-1.75 %)
PREV CLOSE ( ) 191.40
OPEN PRICE ( ) 190.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3957
TODAY'S LOW / HIGH ( )187.00 194.00
52 WK LOW / HIGH ( )76.08 230
NSE188.60-4.1 (-2.13 %)
PREV CLOSE( ) 192.70
OPEN PRICE ( ) 192.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 84444
TODAY'S LOW / HIGH( ) 186.50 194.95
52 WK LOW / HIGH ( )76.1 229.8
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 16-03 1988
Management Info
- Chairman P Shivakumar - Managing Director
Registered Office

Address Sarita Vihar,Delhi - Mathura Road,,
New Delhi,
Delhi-110076

Phone 011- 26925858 / 26925801

Email imcl@apollohospitals.com

Website www.apollohospdelhi.com

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE, MCX

NEWS

23Feb Appointment of Director
Inter alia, approved:- 1.Appointment of Mr. Sandip Somany (DIN 00053597..
05Dec Clarification/ Confirmation On News I
this is with reference to certain allegations made in the UK''s Telegrap..
02Dec Indraprastha Medical Corporation infor
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
29Aug Indraprastha Medical Corporation infor
Pursuant to Regulation 30 read with Schedule III (Part A) of the SEBI (L..
05Jul Indraprastha Medical Corp informs abou
Indraprastha Medical Corp has informed that the Exchange has received th..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit294.4861.499999999999
Gross Profit 406.7 1171.8
Operating Profit 515.71607.3
Net Sales 3064.610986.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  6618.50 (0.61%)
M.Cap ( in Cr)95163.88
Jupiter Life Line (BSE)
peergroup  1487.65 (1.35%)
M.Cap ( in Cr)9753.93
Aster DM Healthcare (BSE)
peergroup  474.70 (4.06%)
M.Cap ( in Cr)23711.88
Max Healthcare Inst (BSE)
peergroup  849.75 (1.74%)
M.Cap ( in Cr)82583.67
Krishna Inst.Medi (BSE)
peergroup  2262.35 (0.57%)
M.Cap ( in Cr)18105.09

Shareholding Pattern

FI/BANKS/INSURANCE 6.36%
PROMOTERS 51%
NON-INSTITUTION 41.68%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Indraprastha Medical Corporation Ltd.

Indraprastha Medical Corporation Ltd. was incorporated in the year 1988. Its today's share price is 188.05. Its current market capitalisation stands at Rs 1723.91 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10986.7 Cr and Total Income of Rs.11087 Cr. The company's management includes P Shivakumar, Suneeta Reddy, Vineeta Rai, Vinayak Chatterjee, Vikram Bhat, Sangita Reddy, S Regunathan, Satnam Arora, Salil Singhal, Menaka Guruswami, Mahesh Verma, Madhumita Ganguli, Deepak Vaidya, Arun Rai, Prathap C Reddy, Priya Ranjan.

It is listed on the BSE with a BSE Code of 532150 , NSE with an NSE Symbol of INDRAMEDCO and ISIN of INE681B01017. It's Registered office is at Sarita Vihar,Delhi - Mathura Road,New Delhi-110076, Delhi. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are SC Vasudeva & Co, SN Dhawan & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.